IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Toshinori Kanamori

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 146(Granted Patents)


Location History:

  • Kasukabe, JP (1987)
  • Saitama, JP (1995 - 1998)
  • Tokyo, JP (1995 - 2001)

Company Filing History:

goldMedal12 out of 227 
 
Mochida Pharmaceutical Co., Ltd.
 patents

Years Active: 1987-2001

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6218134 - Process for specific binding assay for measuring the amount of analyte in a liquid test sample (2001-04-17),
2. 5840518 - DNA fragment, vector containing the DNA fragment, transformant (1998-11-24),
3. 5792629 - Isolated DNA encoding novel protease inhibitory polypeptide (1998-08-11),
4. 5744307 - Method for measuring adenyl group-containing susbstances (1998-04-28),
5. 5679770 - Polypeptide, DNA fragment encoding the same, drug composition containing (1997-10-21),
6. 5594112 - Acridinium compounds and conjugates thereof (1997-01-14),
7. 5589360 - Polypeptide, DNA fragment encoding the same, drug composition containing (1996-12-31),
8. 5516644 - Electrochemical immunochromatographic assay (1996-05-14),
9. 5451659 - Polypeptide, DNA fragment encoding the same, drug composition containing (1995-09-19),
10. 5438139 - Acridinium compounds and conjugates thereof (1995-08-01),
11. 5409895 - Protease inhibitory polypeptides derived from urinary trypsin inhibitor (1995-04-25),
12. 4680261 - Process for producing interferon (1987-07-14),

Title: Innovations of Toshinori Kanamori

Introduction

Toshinori Kanamori is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of assays and DNA technologies. With a total of 12 patents to his name, Kanamori has established himself as a key figure in his industry.

Latest Patents

One of his latest patents includes a process for specific binding assays for measuring the amount of analyte in a liquid test sample. This innovation is crucial for accurate testing in various applications. Additionally, he has developed DNA fragments and vectors containing these fragments, which encode specific amino acid sequences. These advancements are vital for genetic research and therapeutic applications.

Career Highlights

Kanamori works at Mochida Pharmaceutical Co., Ltd., where he has been instrumental in driving research and development initiatives. His expertise in biotechnology has led to numerous breakthroughs that enhance the capabilities of diagnostic tools and treatments.

Collaborations

Some of his notable coworkers include Masahiro Nobuhara and Hideaki Morishita. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Toshinori Kanamori's work exemplifies the spirit of innovation in biotechnology. His patents and contributions continue to impact the field positively, showcasing the importance of research and collaboration in advancing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…